Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001231615-25-000006

Director sold 60,000 shares at an average $121.72 ($7,303,400)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

JEFFS ROGER · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-27 Sale : show line 1 in the form 10b5-1 −20,000 $122.30 $2,446,000 110,974 D
2025-08-28 Sale : show line 2 in the form 10b5-1 −20,000 $121.60 $2,432,000 90,974 D
2025-08-29 Sale : show line 3 in the form 10b5-1 −20,000 $121.27 $2,425,400 70,974 D
Open-market sales · 60,000 sh · avg $121.72 · $7,303,400
Loading xslF345X05/ownership.xml…